These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3520867)
1. [Comparative study of the action of hypolipemic and antioxidant drugs in ischemic heart disease]. Kalmykova VI; Nikitina EK; Bezzubov AA Sov Med; 1986; (3):81-4. PubMed ID: 3520867 [No Abstract] [Full Text] [Related]
2. [Antioxidant therapy in various clinico-biochemical variants of ischemic heart disease]. Dudchenko MA; Rasin MS; Kazakov IuM; Potiazhenko MM; Chichkalo OV Vrach Delo; 1986 Apr; (4):31-3. PubMed ID: 3521087 [No Abstract] [Full Text] [Related]
3. [Study of hypolipemic effect of atheroid in ischemic heart disease associated with various types of hyperlipoproteinemia]. Zakharov VN Sov Med; 1978 Jan; (1):147-8. PubMed ID: 76342 [No Abstract] [Full Text] [Related]
4. [The diagnosis and treatment of coronary heart disease in chronic renal failure]. Belialov FI Klin Med (Mosk); 2004; 82(10):8-12. PubMed ID: 15584591 [No Abstract] [Full Text] [Related]
5. Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study Design. Brown BG; Zhao XQ; Chait A; Frohlich J; Cheung M; Heise N; Dowdy A; DeAngelis D; Fisher LD; Albers J Can J Cardiol; 1998 Apr; 14 Suppl A():6A-13A. PubMed ID: 9594927 [TBL] [Abstract][Full Text] [Related]
6. [A double blind study of the new hypolipidemic agent pirozadil (722-D) using patients with ischemic heart disease (author's transl)]. Cadierno Carpintero M; Emeterio Reig E; Soler Masana JM Med Clin (Barc); 1982 May; 78(9):386-9. PubMed ID: 7047927 [No Abstract] [Full Text] [Related]
7. [Necessity of hypolipemic treatment in patients with coronary disease]. Fernández-Miranda C; Aranda IL Med Clin (Barc); 1999 Mar; 112(11):438. PubMed ID: 10231779 [No Abstract] [Full Text] [Related]
8. Prevention of coronary atherosclerosis by the use of combination therapy with antioxidant coenzyme Q10 and statins. Chapidze G; Kapanadze S; Dolidze N; Bachutashvili Z; Latsabidze N Georgian Med News; 2005 Jan; (118):20-5. PubMed ID: 15821319 [TBL] [Abstract][Full Text] [Related]
9. Does hypolipidemic therapy prevent coronary heart disease? Rifkind BM; Levy RI Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303 [No Abstract] [Full Text] [Related]
10. [Experimental and clinical assessment of antioxidant efficacy of multicomponent antioxidant medication]. Lankin VZ; Tikhaze AK; Konovalova GG; Lisina MO; Nezhdanova IB; Gamboeva SB; Kukharchuk VV; Belenkov IuN Ter Arkh; 2004; 76(8):10-5. PubMed ID: 15471387 [TBL] [Abstract][Full Text] [Related]
11. [Effect of hypolipidemic agents on the content of sterol-fibrinogen complexes of the blood in patients with ischemic heart disease]. Palamarchuk VI; Fedorishko SS Vrach Delo; 1989 Jan; (1):39-41. PubMed ID: 2718441 [TBL] [Abstract][Full Text] [Related]
12. Lipids and their role in coronary heart disease: what they do and how to manage them. Pradka LR Nurs Clin North Am; 2000 Dec; 35(4):981-91. PubMed ID: 11072283 [TBL] [Abstract][Full Text] [Related]
13. Trials and tribulations. Packard CJ Int J Clin Pract Suppl; 2002 Oct; (132):3-10. PubMed ID: 12425357 [No Abstract] [Full Text] [Related]
14. [Treatment of atherosclerosis with hypolipidemic and antiuricemic agents]. Plastinina RA; Oleĭnik NA; Valeeva RM; Pavlova TN Sov Med; 1984; (1):83-7. PubMed ID: 6701660 [No Abstract] [Full Text] [Related]
15. [Effect of the antioxidant dibunol on the composition and lipid peroxidation intensity of the blood of ischemic heart disease patients]. Sal'nikov MI; Barsel' VA; Arkhipova GV Dokl Akad Nauk SSSR; 1984; 278(3):747-51. PubMed ID: 6499651 [No Abstract] [Full Text] [Related]